kidney disease glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 Obesity Drugs Also Provide
Description
Iwasaki Y, Sendo M, Dezaki K, Hira T, Sato T, Nakata M, et al
Supports overall daily wellness
Participants Adult patients with diabetes who were newly prescribed add-on non-insulin glucose-lowering agents and were on metformin between 2005-2020
Promoting Adherence to GLP-1 Receptor Agonist Therapy
A study assessed the kidney benefits of metabolic surgery compared to glucagon-like peptide-1 receptor agonist treatment in patients with obesity and chronic kidney disease (CKD).
